Statins in HIV-associated lipodystrophy and metabolic syndrome: is there a missing link?

This publication has 13 references indexed in Scilit:

• Effects of statins on endothelial function and lipid profile in HIV infected persons receiving protease inhibitor-containing anti-retroviral combination therapy: a randomised double blind crossover trial
  Heart, 2006
• The Potential Relevance of the Multiple Lipid-Independent (Pleiotropic) Effects of Statins in the Management of Acute Coronary Syndromes
  Journal of the American College of Cardiology, 2005
• Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins
  The Lancet, 2005
• Rosuvastatin for the treatment of hyperlipidaemia in HIV-infected patients receiving protease inhibitors: a pilot study
  AIDS, 2005
• Cardiovascular Risk and Body-Fat Abnormalities in HIV-Infected Adults
  New England Journal of Medicine, 2005
• Effects of pravastatin on lipoproteins and endothelial function in patients receiving human immunodeficiency virus protease inhibitors
  American Heart Journal, 2004
• Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir
  AIDS, 2004
• Some HIV protease inhibitors alter lamin A/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation
  AIDS, 2003
• Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group
  Clinical Infectious Diseases, 2003
• Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: acohort study
  The Lancet, 1999